

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine biosynthetic process (GO:0045080) | 6.07262786 |
| 2 | hydrogen peroxide biosynthetic process (GO:0050665) | 6.02551484 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.86843936 |
| 4 | response to peptidoglycan (GO:0032494) | 5.74905275 |
| 5 | reactive oxygen species biosynthetic process (GO:1903409) | 5.35255136 |
| 6 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.31843855 |
| 7 | regulation of chemokine biosynthetic process (GO:0045073) | 5.17565987 |
| 8 | superoxide anion generation (GO:0042554) | 5.12355674 |
| 9 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.99824985 |
| 10 | positive regulation of heat generation (GO:0031652) | 4.92894645 |
| 11 | respiratory burst (GO:0045730) | 4.89827493 |
| 12 | regulation of fever generation (GO:0031620) | 4.88558609 |
| 13 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.79481834 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.79016452 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.79016452 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.79016452 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.79016452 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.79016452 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.79016452 |
| 20 | granulocyte activation (GO:0036230) | 4.70357760 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58667848 |
| 22 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.50030994 |
| 23 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.46367158 |
| 24 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.41351683 |
| 25 | positive regulation of mast cell degranulation (GO:0043306) | 4.41351683 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 4.35374401 |
| 27 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.32916943 |
| 28 | neutrophil activation (GO:0042119) | 4.32788328 |
| 29 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.29070495 |
| 30 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.12400793 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 4.01451478 |
| 32 | leukocyte aggregation (GO:0070486) | 4.01174327 |
| 33 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.96547068 |
| 34 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.93734535 |
| 35 | regulation of chronic inflammatory response (GO:0002676) | 3.92236717 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.90205206 |
| 37 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.89926492 |
| 38 | eosinophil chemotaxis (GO:0048245) | 3.86422078 |
| 39 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.86065627 |
| 40 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.77861856 |
| 41 | cellular response to zinc ion (GO:0071294) | 3.77500369 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.76861925 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 3.74180308 |
| 44 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.71334346 |
| 45 | regulation of heat generation (GO:0031650) | 3.68891984 |
| 46 | positive regulation of mast cell activation (GO:0033005) | 3.68252480 |
| 47 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.65969645 |
| 48 | negative regulation of lipid storage (GO:0010888) | 3.64646865 |
| 49 | regulation of mast cell degranulation (GO:0043304) | 3.63226611 |
| 50 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.62680790 |
| 51 | regulation of podosome assembly (GO:0071801) | 3.58686631 |
| 52 | regulation of mononuclear cell migration (GO:0071675) | 3.57985209 |
| 53 | regulation of interferon-alpha production (GO:0032647) | 3.55125128 |
| 54 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.54922790 |
| 55 | detection of molecule of bacterial origin (GO:0032490) | 3.54309812 |
| 56 | NIK/NF-kappaB signaling (GO:0038061) | 3.53188532 |
| 57 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.53099648 |
| 58 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.51987527 |
| 59 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.49805798 |
| 60 | cellular response to lipopolysaccharide (GO:0071222) | 3.49288499 |
| 61 | negative regulation of interleukin-12 production (GO:0032695) | 3.49177839 |
| 62 | response to protozoan (GO:0001562) | 3.47788590 |
| 63 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.46961401 |
| 64 | monocyte chemotaxis (GO:0002548) | 3.46366802 |
| 65 | regulation of vitamin metabolic process (GO:0030656) | 3.45511502 |
| 66 | eosinophil migration (GO:0072677) | 3.42254250 |
| 67 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.38213490 |
| 68 | myeloid cell activation involved in immune response (GO:0002275) | 3.37214707 |
| 69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.36561349 |
| 70 | cellular response to molecule of bacterial origin (GO:0071219) | 3.35249064 |
| 71 | positive regulation of leukocyte degranulation (GO:0043302) | 3.34471185 |
| 72 | cellular response to nicotine (GO:0071316) | 3.33779840 |
| 73 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.32071025 |
| 74 | positive regulation of chemokine production (GO:0032722) | 3.30549571 |
| 75 | response to manganese ion (GO:0010042) | 3.30338615 |
| 76 | glycosphingolipid catabolic process (GO:0046479) | 3.29958157 |
| 77 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.29820073 |
| 78 | macrophage activation (GO:0042116) | 3.28597210 |
| 79 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.26997014 |
| 80 | B cell mediated immunity (GO:0019724) | 3.26208228 |
| 81 | positive regulation of acute inflammatory response (GO:0002675) | 3.24101815 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23746369 |
| 83 | germinal center formation (GO:0002467) | 3.23170092 |
| 84 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.22252328 |
| 85 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.22185739 |
| 86 | regulation of mast cell activation (GO:0033003) | 3.21510019 |
| 87 | oligosaccharide catabolic process (GO:0009313) | 3.21383718 |
| 88 | defense response to protozoan (GO:0042832) | 3.20388043 |
| 89 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.17017749 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.16033380 |
| 91 | negative regulation of interleukin-17 production (GO:0032700) | 3.15008813 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14529487 |
| 93 | low-density lipoprotein particle clearance (GO:0034383) | 3.13515390 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 3.13333853 |
| 95 | regulation of prostaglandin secretion (GO:0032306) | 3.12988068 |
| 96 | regulation of immunoglobulin secretion (GO:0051023) | 3.11274286 |
| 97 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.10845929 |
| 98 | response to host immune response (GO:0052572) | 3.10845929 |
| 99 | activation of MAPKKK activity (GO:0000185) | 3.10381196 |
| 100 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.10231872 |
| 101 | positive regulation of humoral immune response (GO:0002922) | 3.09942010 |
| 102 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.09646813 |
| 103 | positive regulation of prostaglandin secretion (GO:0032308) | 3.09219302 |
| 104 | T-helper 1 type immune response (GO:0042088) | 3.05415342 |
| 105 | natural killer cell mediated immunity (GO:0002228) | 3.04398809 |
| 106 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.04398809 |
| 107 | positive regulation of interleukin-6 production (GO:0032755) | 3.03645089 |
| 108 | phagosome maturation (GO:0090382) | 3.03175466 |
| 109 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.02932763 |
| 110 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.00525533 |
| 111 | positive regulation of transcription factor import into nucleus (GO:0042993) | 3.00216403 |
| 112 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.98060697 |
| 113 | positive regulation of lymphocyte migration (GO:2000403) | 2.97871650 |
| 114 | lymphocyte chemotaxis (GO:0048247) | 2.97334924 |
| 115 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.96063643 |
| 116 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.96063643 |
| 117 | regulation of growth of symbiont in host (GO:0044126) | 2.96063643 |
| 118 | negative regulation of growth of symbiont in host (GO:0044130) | 2.96063643 |
| 119 | glycolipid catabolic process (GO:0019377) | 2.94484073 |
| 120 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.93921324 |
| 121 | myeloid dendritic cell differentiation (GO:0043011) | 2.93231295 |
| 122 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.91497219 |
| 123 | cytokine secretion (GO:0050663) | 2.90425183 |
| 124 | cellular response to biotic stimulus (GO:0071216) | 2.90405906 |
| 125 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.90095271 |
| 126 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89512679 |
| 127 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.88868959 |
| 128 | regulation of interleukin-6 production (GO:0032675) | 2.87724696 |
| 129 | positive regulation of interleukin-12 production (GO:0032735) | 2.87360506 |
| 130 | microglial cell activation (GO:0001774) | 2.86826107 |
| 131 | negative regulation of glucose transport (GO:0010829) | 2.85841466 |
| 132 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.84606350 |
| 133 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.83814814 |
| 134 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.81339483 |
| 135 | cellular extravasation (GO:0045123) | 2.79731096 |
| 136 | regulation of macrophage chemotaxis (GO:0010758) | 2.76776963 |
| 137 | regulation of interleukin-12 production (GO:0032655) | 2.74445223 |
| 138 | decidualization (GO:0046697) | 2.71617258 |
| 139 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.71550261 |
| 140 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.68753131 |
| 141 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.66959726 |
| 142 | type I interferon signaling pathway (GO:0060337) | 2.66382813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.57194426 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.06505982 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.50394836 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.24117438 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.16365327 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.98791058 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.96204581 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.81978218 |
| 9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.62740648 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.50450215 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.05066899 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.86364423 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71995905 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.71596107 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56014902 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.46619347 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39179491 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32261069 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.30643168 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.28167327 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86290506 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85168660 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.83082202 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82048255 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.71572965 |
| 26 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70158272 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68603944 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63218309 |
| 29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62324235 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62084840 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61435885 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60832639 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55664798 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55545860 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54845455 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50857991 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50641688 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.48566220 |
| 39 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.48232011 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.48232011 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44138167 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42626219 |
| 43 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38940973 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38110842 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37816172 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36667558 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35099044 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34698171 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31803790 |
| 50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29973700 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25541675 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24532859 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23948460 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21723911 |
| 55 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19991017 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17521764 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16089586 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.14328200 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12243767 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11957902 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09515868 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08765159 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06499295 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05309012 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04534498 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04483641 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01334664 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99883660 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98940487 |
| 70 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.98361168 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97286133 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96951769 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96857407 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96598767 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96158106 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95382691 |
| 77 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95181688 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94789711 |
| 79 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.94240105 |
| 80 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.94240105 |
| 81 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.94240105 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93498757 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92246086 |
| 84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91907601 |
| 85 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91803969 |
| 86 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90445430 |
| 87 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90039017 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.89614175 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88506446 |
| 90 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.87963677 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86195095 |
| 92 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85902375 |
| 93 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.84725635 |
| 94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83211030 |
| 95 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.82582803 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 0.82076381 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81961690 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80164088 |
| 99 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79994955 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.76735335 |
| 101 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76102712 |
| 102 | MYB_26560356_Chip-Seq_TH1_Human | 0.76075293 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75493676 |
| 104 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74382685 |
| 105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73784056 |
| 106 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73784056 |
| 107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.73044847 |
| 108 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70735766 |
| 109 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70284922 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.70136602 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.69762720 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.66025359 |
| 113 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.65686472 |
| 114 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.63034176 |
| 115 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.62366582 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.62086125 |
| 117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.56996409 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56974366 |
| 119 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.55988538 |
| 120 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.52702793 |
| 121 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.52611684 |
| 122 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.52321512 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.50054885 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.49193040 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48408448 |
| 126 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.47953605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.66389082 |
| 2 | MP0009785_altered_susceptibility_to | 4.60401507 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.42354955 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 4.08190782 |
| 5 | MP0002419_abnormal_innate_immunity | 3.59250452 |
| 6 | MP0003724_increased_susceptibility_to | 3.52882358 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.51804392 |
| 8 | MP0006082_CNS_inflammation | 3.45942085 |
| 9 | MP0003303_peritoneal_inflammation | 3.26075028 |
| 10 | MP0005025_abnormal_response_to | 3.23782040 |
| 11 | MP0009840_abnormal_foam_cell | 3.05150788 |
| 12 | MP0005671_abnormal_response_to | 2.65861913 |
| 13 | MP0009764_decreased_sensitivity_to | 2.63725329 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.60072143 |
| 15 | MP0004510_myositis | 2.57157429 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.47326855 |
| 17 | MP0002723_abnormal_immune_serum | 2.46229339 |
| 18 | MP0001790_abnormal_immune_system | 2.42704309 |
| 19 | MP0005387_immune_system_phenotype | 2.42704309 |
| 20 | MP0003195_calcinosis | 2.42527633 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.40738299 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.31391529 |
| 23 | MP0000685_abnormal_immune_system | 2.24811324 |
| 24 | MP0001800_abnormal_humoral_immune | 2.22509556 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 2.15696195 |
| 26 | MP0001819_abnormal_immune_cell | 2.12115561 |
| 27 | MP0002420_abnormal_adaptive_immunity | 2.09504447 |
| 28 | MP0003646_muscle_fatigue | 2.06690389 |
| 29 | MP0003075_altered_response_to | 2.05476512 |
| 30 | MP0002006_tumorigenesis | 2.03905941 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.99967074 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.98876711 |
| 33 | MP0004947_skin_inflammation | 1.98824472 |
| 34 | MP0001853_heart_inflammation | 1.95354435 |
| 35 | MP0002405_respiratory_system_inflammati | 1.94193120 |
| 36 | MP0003448_altered_tumor_morphology | 1.88504657 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.88089787 |
| 38 | MP0003186_abnormal_redox_activity | 1.87888614 |
| 39 | MP0009278_abnormal_bone_marrow | 1.84610708 |
| 40 | MP0000343_altered_response_to | 1.76994823 |
| 41 | MP0008469_abnormal_protein_level | 1.76819039 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.75911791 |
| 43 | MP0000858_altered_metastatic_potential | 1.65887496 |
| 44 | MP0006054_spinal_hemorrhage | 1.65678415 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.56715675 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.55989485 |
| 47 | MP0005166_decreased_susceptibility_to | 1.51798214 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.51227706 |
| 49 | MP0005164_abnormal_response_to | 1.41736064 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.40552213 |
| 51 | MP0000716_abnormal_immune_system | 1.38058399 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.37376727 |
| 53 | MP0005310_abnormal_salivary_gland | 1.29776574 |
| 54 | MP0003828_pulmonary_edema | 1.26609148 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.25170841 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.25170841 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.20409169 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.15839482 |
| 59 | MP0005390_skeleton_phenotype | 1.13944785 |
| 60 | MP0002398_abnormal_bone_marrow | 1.12012648 |
| 61 | MP0005023_abnormal_wound_healing | 1.05707651 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.05303721 |
| 63 | MP0002429_abnormal_blood_cell | 1.04131089 |
| 64 | MP0009765_abnormal_xenobiotic_induced | 1.03272614 |
| 65 | MP0008260_abnormal_autophagy | 0.99890185 |
| 66 | MP0009763_increased_sensitivity_to | 0.97396321 |
| 67 | MP0005451_abnormal_body_composition | 0.95428609 |
| 68 | MP0005076_abnormal_cell_differentiation | 0.94663508 |
| 69 | MP0000689_abnormal_spleen_morphology | 0.89113403 |
| 70 | MP0000371_diluted_coat_color | 0.89073991 |
| 71 | MP0001542_abnormal_bone_strength | 0.86654347 |
| 72 | MP0005535_abnormal_body_temperature | 0.85802175 |
| 73 | MP0000604_amyloidosis | 0.85510389 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 0.84566594 |
| 75 | MP0002933_joint_inflammation | 0.83487990 |
| 76 | MP0003690_abnormal_glial_cell | 0.83150129 |
| 77 | MP0008874_decreased_physiological_sensi | 0.81135114 |
| 78 | MP0005647_abnormal_sex_gland | 0.81123456 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.80328163 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 0.79927438 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.79667850 |
| 82 | MP0002722_abnormal_immune_system | 0.79027827 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.77024129 |
| 84 | MP0003329_amyloid_beta_deposits | 0.76665265 |
| 85 | MP0000249_abnormal_blood_vessel | 0.75566573 |
| 86 | MP0005595_abnormal_vascular_smooth | 0.75493901 |
| 87 | MP0002254_reproductive_system_inflammat | 0.75176726 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.75003795 |
| 89 | MP0001851_eye_inflammation | 0.73089238 |
| 90 | MP0010386_abnormal_urinary_bladder | 0.70623770 |
| 91 | MP0001727_abnormal_embryo_implantation | 0.70106311 |
| 92 | MP0001849_ear_inflammation | 0.69487075 |
| 93 | MP0003795_abnormal_bone_structure | 0.66602651 |
| 94 | MP0004883_abnormal_blood_vessel | 0.65983519 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 0.62241024 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.60215685 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.60189558 |
| 98 | MP0000750_abnormal_muscle_regeneration | 0.59819419 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.58039526 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.58005175 |
| 101 | MP0000767_abnormal_smooth_muscle | 0.56673239 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.55811072 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.55688230 |
| 104 | MP0003091_abnormal_cell_migration | 0.54428200 |
| 105 | MP0003279_aneurysm | 0.53311551 |
| 106 | MP0003045_fibrosis | 0.52711483 |
| 107 | MP0008004_abnormal_stomach_pH | 0.52598790 |
| 108 | MP0004858_abnormal_nervous_system | 0.52376559 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.50728094 |
| 110 | MP0001663_abnormal_digestive_system | 0.49046491 |
| 111 | MP0005165_increased_susceptibility_to | 0.48417307 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.47943245 |
| 113 | MP0002090_abnormal_vision | 0.47898201 |
| 114 | MP0005171_absent_coat_pigmentation | 0.47632765 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.46288891 |
| 116 | MP0008873_increased_physiological_sensi | 0.46253272 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.45982420 |
| 118 | MP0005257_abnormal_intraocular_pressure | 0.45903807 |
| 119 | MP0009697_abnormal_copulation | 0.45716644 |
| 120 | MP0000920_abnormal_myelination | 0.44910087 |
| 121 | MP0001881_abnormal_mammary_gland | 0.44049155 |
| 122 | MP0005408_hypopigmentation | 0.43119506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.48894967 |
| 2 | Eczematoid dermatitis (HP:0000976) | 8.17325141 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.66532076 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.48461249 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 6.31195521 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.56670623 |
| 7 | Stomatitis (HP:0010280) | 5.48033335 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 4.85832315 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.83161726 |
| 10 | Gingivitis (HP:0000230) | 4.79315519 |
| 11 | Dysostosis multiplex (HP:0000943) | 4.48032981 |
| 12 | Recurrent skin infections (HP:0001581) | 4.45779175 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.44756073 |
| 14 | Optic neuritis (HP:0100653) | 4.44756073 |
| 15 | Increased IgM level (HP:0003496) | 4.41889045 |
| 16 | Obstructive lung disease (HP:0006536) | 4.40436625 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 4.40436625 |
| 18 | Loss of speech (HP:0002371) | 4.38351106 |
| 19 | Myositis (HP:0100614) | 4.28165726 |
| 20 | Orchitis (HP:0100796) | 4.27235584 |
| 21 | Mutism (HP:0002300) | 3.89646149 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.82109124 |
| 23 | Vasculitis (HP:0002633) | 3.77410528 |
| 24 | Axonal loss (HP:0003447) | 3.72803946 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.62052848 |
| 26 | Prostate neoplasm (HP:0100787) | 3.52968054 |
| 27 | Nuclear cataract (HP:0100018) | 3.51185673 |
| 28 | Urticaria (HP:0001025) | 3.44301687 |
| 29 | Tetraparesis (HP:0002273) | 3.35674671 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.24428392 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.24428392 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.24428392 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.18092311 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 3.14373246 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.13432722 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.13128350 |
| 37 | Recurrent viral infections (HP:0004429) | 3.08996828 |
| 38 | Apathy (HP:0000741) | 3.06083564 |
| 39 | Cellulitis (HP:0100658) | 3.05815741 |
| 40 | Basal ganglia calcification (HP:0002135) | 3.04358874 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03328066 |
| 42 | Mucopolysacchariduria (HP:0008155) | 3.03328066 |
| 43 | Diminished motivation (HP:0000745) | 3.00671150 |
| 44 | Periodontitis (HP:0000704) | 3.00054883 |
| 45 | Amyloidosis (HP:0011034) | 2.98338002 |
| 46 | Thick nail (HP:0001805) | 2.93014362 |
| 47 | Recurrent pneumonia (HP:0006532) | 2.92842252 |
| 48 | Glomerulonephritis (HP:0000099) | 2.89651429 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89574723 |
| 50 | Metaphyseal irregularity (HP:0003025) | 2.87255259 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.86853190 |
| 52 | Pustule (HP:0200039) | 2.83005299 |
| 53 | Meningitis (HP:0001287) | 2.80498294 |
| 54 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.78804328 |
| 55 | Poor head control (HP:0002421) | 2.74127218 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.73883926 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.71861751 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.70364925 |
| 59 | Premature loss of primary teeth (HP:0006323) | 2.62780963 |
| 60 | Gingival bleeding (HP:0000225) | 2.61857389 |
| 61 | Leukocytosis (HP:0001974) | 2.59595158 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.57074272 |
| 63 | Disinhibition (HP:0000734) | 2.56945765 |
| 64 | Abnormality of iron homeostasis (HP:0011031) | 2.56810147 |
| 65 | Nausea (HP:0002018) | 2.53125170 |
| 66 | Neuronal loss in central nervous system (HP:0002529) | 2.53120479 |
| 67 | Vertebral compression fractures (HP:0002953) | 2.52709769 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.47960955 |
| 69 | Joint hemorrhage (HP:0005261) | 2.44493116 |
| 70 | Recurrent lower respiratory tract infections (HP:0002783) | 2.43636472 |
| 71 | Arterial thrombosis (HP:0004420) | 2.41833603 |
| 72 | Abnormality of the pericardium (HP:0001697) | 2.40483596 |
| 73 | Peritonitis (HP:0002586) | 2.40473232 |
| 74 | Osteomyelitis (HP:0002754) | 2.39350462 |
| 75 | Progressive neurologic deterioration (HP:0002344) | 2.38873181 |
| 76 | Inappropriate behavior (HP:0000719) | 2.37927518 |
| 77 | Bone pain (HP:0002653) | 2.37457401 |
| 78 | Abnormality of T cell number (HP:0011839) | 2.35021542 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.32668048 |
| 80 | Polyneuropathy (HP:0001271) | 2.28768237 |
| 81 | Sepsis (HP:0100806) | 2.28668825 |
| 82 | Myocardial infarction (HP:0001658) | 2.28367013 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.27862803 |
| 84 | Hemoptysis (HP:0002105) | 2.27064501 |
| 85 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26159425 |
| 86 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26159425 |
| 87 | Malnutrition (HP:0004395) | 2.25521833 |
| 88 | Joint swelling (HP:0001386) | 2.25245313 |
| 89 | Nephritis (HP:0000123) | 2.24298903 |
| 90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22613217 |
| 91 | Purpura (HP:0000979) | 2.18705377 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18380037 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18380037 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18380037 |
| 95 | Arthralgia (HP:0002829) | 2.18067389 |
| 96 | Prolonged neonatal jaundice (HP:0006579) | 2.14862112 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09817407 |
| 98 | Parakeratosis (HP:0001036) | 2.09357959 |
| 99 | Gangrene (HP:0100758) | 2.08587328 |
| 100 | Complement deficiency (HP:0004431) | 2.07554195 |
| 101 | Anorexia (HP:0002039) | 2.07342342 |
| 102 | Petechiae (HP:0000967) | 2.04730339 |
| 103 | Asymmetric septal hypertrophy (HP:0001670) | 2.04496482 |
| 104 | Upper motor neuron abnormality (HP:0002127) | 2.03085882 |
| 105 | Hepatosplenomegaly (HP:0001433) | 2.02131717 |
| 106 | Esophageal neoplasm (HP:0100751) | 2.00019265 |
| 107 | Neoplasm of head and neck (HP:0012288) | 2.00019265 |
| 108 | Dementia (HP:0000726) | 1.99739358 |
| 109 | Abnormality of the prostate (HP:0008775) | 1.98467457 |
| 110 | Agnosia (HP:0010524) | 1.97362736 |
| 111 | Episodic fever (HP:0001954) | 1.96520166 |
| 112 | Chronic otitis media (HP:0000389) | 1.94220781 |
| 113 | Combined immunodeficiency (HP:0005387) | 1.93862667 |
| 114 | Conjunctival telangiectasia (HP:0000524) | 1.93856351 |
| 115 | T lymphocytopenia (HP:0005403) | 1.92186310 |
| 116 | Hematochezia (HP:0002573) | 1.91311075 |
| 117 | Abnormality of the pleura (HP:0002103) | 1.90745786 |
| 118 | Personality changes (HP:0000751) | 1.89707290 |
| 119 | Esophageal varix (HP:0002040) | 1.89593466 |
| 120 | Vertigo (HP:0002321) | 1.87980510 |
| 121 | Autoimmune hemolytic anemia (HP:0001890) | 1.85785299 |
| 122 | Thin bony cortex (HP:0002753) | 1.85450992 |
| 123 | Supranuclear gaze palsy (HP:0000605) | 1.84052111 |
| 124 | Hydroxyprolinuria (HP:0003080) | 1.82543412 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 1.82543412 |
| 126 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81962356 |
| 127 | Increased serum ferritin (HP:0003281) | 1.80231321 |
| 128 | Porencephaly (HP:0002132) | 1.79491461 |
| 129 | Memory impairment (HP:0002354) | 1.79126258 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.78659892 |
| 131 | Skin ulcer (HP:0200042) | 1.75916458 |
| 132 | Lymphopenia (HP:0001888) | 1.71755726 |
| 133 | Restrictive lung disease (HP:0002091) | 1.70746977 |
| 134 | Epistaxis (HP:0000421) | 1.70154127 |
| 135 | Xerostomia (HP:0000217) | 1.69961202 |
| 136 | Pathologic fracture (HP:0002756) | 1.69852400 |
| 137 | Osteolytic defects of the hand bones (HP:0009699) | 1.68548412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 7.39517922 |
| 2 | PBK | 5.50696609 |
| 3 | MAP3K14 | 4.86468590 |
| 4 | TBK1 | 3.75387653 |
| 5 | BLK | 3.50332489 |
| 6 | IRAK3 | 2.85061622 |
| 7 | IKBKB | 2.43413073 |
| 8 | JAK3 | 2.41848712 |
| 9 | IRAK4 | 2.40823538 |
| 10 | TAOK1 | 2.33795964 |
| 11 | TXK | 2.33436961 |
| 12 | IKBKE | 2.31090116 |
| 13 | MAP3K3 | 2.26022757 |
| 14 | TYK2 | 2.05126896 |
| 15 | MST1R | 1.91688510 |
| 16 | BMPR2 | 1.74910432 |
| 17 | MST4 | 1.70584620 |
| 18 | MAP3K13 | 1.69325198 |
| 19 | MAP2K3 | 1.66849149 |
| 20 | TGFBR2 | 1.62136177 |
| 21 | YES1 | 1.57354224 |
| 22 | CSK | 1.55296949 |
| 23 | CHUK | 1.48730744 |
| 24 | BMX | 1.48679120 |
| 25 | JAK1 | 1.47580243 |
| 26 | CDC42BPA | 1.45722238 |
| 27 | FGR | 1.33260639 |
| 28 | ACVR1B | 1.32076685 |
| 29 | ABL2 | 1.30155614 |
| 30 | MATK | 1.29750480 |
| 31 | TYRO3 | 1.24329994 |
| 32 | ERBB4 | 1.24317307 |
| 33 | ERN1 | 1.24250231 |
| 34 | PIM2 | 1.22885349 |
| 35 | LYN | 1.16684789 |
| 36 | MAP4K1 | 1.16058484 |
| 37 | SIK3 | 1.15685105 |
| 38 | NME2 | 1.13945378 |
| 39 | RPS6KA4 | 1.08369131 |
| 40 | STK4 | 1.01629851 |
| 41 | SYK | 1.00773231 |
| 42 | MARK3 | 0.99396851 |
| 43 | LATS2 | 0.95098152 |
| 44 | PIM1 | 0.91460613 |
| 45 | KIT | 0.91444685 |
| 46 | PDGFRA | 0.90610503 |
| 47 | ERBB3 | 0.90105089 |
| 48 | LCK | 0.88331314 |
| 49 | PRKCD | 0.87393646 |
| 50 | JAK2 | 0.86451749 |
| 51 | HCK | 0.85314359 |
| 52 | EIF2AK2 | 0.81260814 |
| 53 | ZAP70 | 0.80110418 |
| 54 | KSR2 | 0.79816948 |
| 55 | ARAF | 0.73965838 |
| 56 | DAPK2 | 0.71367909 |
| 57 | MAP3K5 | 0.71041809 |
| 58 | RIPK1 | 0.66911243 |
| 59 | BTK | 0.65270746 |
| 60 | TRPM7 | 0.63655309 |
| 61 | CLK1 | 0.63337838 |
| 62 | ABL1 | 0.63073181 |
| 63 | EGFR | 0.56751630 |
| 64 | TESK2 | 0.56175896 |
| 65 | BMPR1B | 0.55893145 |
| 66 | PRPF4B | 0.54296511 |
| 67 | TEC | 0.53512029 |
| 68 | MAPK4 | 0.53017033 |
| 69 | PDPK1 | 0.51577354 |
| 70 | MAP3K12 | 0.47796227 |
| 71 | STK3 | 0.47512969 |
| 72 | CSF1R | 0.47271814 |
| 73 | MAP2K6 | 0.46132788 |
| 74 | ADRBK2 | 0.45223351 |
| 75 | EPHB1 | 0.44994042 |
| 76 | PAK4 | 0.44740011 |
| 77 | MET | 0.44729521 |
| 78 | DAPK3 | 0.43298948 |
| 79 | NEK9 | 0.41843893 |
| 80 | PDK1 | 0.41500486 |
| 81 | STK10 | 0.41429540 |
| 82 | GRK7 | 0.40161224 |
| 83 | PRKCQ | 0.39754412 |
| 84 | MOS | 0.38297311 |
| 85 | RPS6KC1 | 0.38076469 |
| 86 | RPS6KL1 | 0.38076469 |
| 87 | FGFR3 | 0.37747520 |
| 88 | IRAK2 | 0.37129192 |
| 89 | BCR | 0.37029791 |
| 90 | PIK3CG | 0.36872569 |
| 91 | SIK1 | 0.36458584 |
| 92 | DYRK3 | 0.36255897 |
| 93 | CDK6 | 0.36125326 |
| 94 | CAMKK2 | 0.35682622 |
| 95 | FES | 0.35584553 |
| 96 | FYN | 0.35141625 |
| 97 | TESK1 | 0.34682713 |
| 98 | PDGFRB | 0.34108107 |
| 99 | ADRBK1 | 0.33832904 |
| 100 | PKN1 | 0.32465437 |
| 101 | STK24 | 0.30646582 |
| 102 | DDR2 | 0.30378397 |
| 103 | MUSK | 0.30035916 |
| 104 | IRAK1 | 0.29530413 |
| 105 | GSK3A | 0.29414967 |
| 106 | MAP3K9 | 0.28864930 |
| 107 | TAOK3 | 0.27396669 |
| 108 | MAP3K1 | 0.26750839 |
| 109 | PLK2 | 0.26299523 |
| 110 | NLK | 0.25545366 |
| 111 | INSR | 0.25508891 |
| 112 | MAP3K11 | 0.25478450 |
| 113 | IGF1R | 0.24432329 |
| 114 | PRKCE | 0.23732211 |
| 115 | PRKCZ | 0.20803893 |
| 116 | PDK2 | 0.20562574 |
| 117 | CDK4 | 0.18788520 |
| 118 | SIK2 | 0.18452059 |
| 119 | MAP3K8 | 0.18089592 |
| 120 | TAOK2 | 0.17826344 |
| 121 | RAF1 | 0.17441367 |
| 122 | CAMK1D | 0.17206398 |
| 123 | PRKG2 | 0.16912708 |
| 124 | TTN | 0.16395302 |
| 125 | RPS6KA1 | 0.16306193 |
| 126 | RPS6KA6 | 0.16053039 |
| 127 | MAPK7 | 0.14016397 |
| 128 | EPHA3 | 0.13905581 |
| 129 | RPS6KA2 | 0.13695246 |
| 130 | KSR1 | 0.13007331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.71534616 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.55511903 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.27499379 |
| 4 | * Legionellosis_Homo sapiens_hsa05134 | 3.14995780 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.99590697 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.99475747 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.90318014 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.84421471 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.83388409 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.79570947 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.73968674 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.48529109 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.40520459 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.39676498 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.37299400 |
| 16 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.22808237 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 2.20190610 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14334485 |
| 19 | * Salmonella infection_Homo sapiens_hsa05132 | 2.08406152 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05654368 |
| 21 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.05165533 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.81035440 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.75414608 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68384099 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.59577593 |
| 26 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49369345 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44615447 |
| 28 | Bladder cancer_Homo sapiens_hsa05219 | 1.39535689 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36062822 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29632333 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27229683 |
| 32 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25615298 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24551120 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.19922864 |
| 35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19460028 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.15072565 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11634106 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09072832 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08314103 |
| 40 | Amoebiasis_Homo sapiens_hsa05146 | 1.06862150 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.05505240 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.03582485 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01071659 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92514413 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90460988 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.79912914 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77338123 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 0.75096443 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74237503 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71335673 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70349447 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.70338701 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70291631 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68900014 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62958522 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60953639 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60896364 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59425534 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57085410 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56776129 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50977748 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49886678 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49698135 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47905156 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47899576 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45419271 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 0.44042975 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43082020 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41975463 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40970982 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40300025 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38834344 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38830125 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38544781 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35919722 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35093412 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33141196 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.32624574 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31196304 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.30181871 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29247356 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27728670 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27057384 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26398517 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25077483 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21321832 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20832430 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20683550 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18588184 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17234326 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.16792518 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15089264 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15004552 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.13622752 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13614684 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13179779 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12040470 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.11584035 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11570346 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.11389584 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.11100132 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09567722 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.08380985 |
| 104 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.07676653 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.07360331 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.05011383 |
| 107 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.04727531 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.04387552 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.03682344 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.02928517 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.01867959 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.00121670 |

